Submitted:
01 September 2023
Posted:
05 September 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. In vitro stage of experiment
Getting primary cells cultures of the brain in vitro
- Extraction of cerebral endothelial cells
- Extraction and cultivation of neurospheres.
- Extraction of astrocytes and neurons from these neurospheres we got earlier using directional differentiating in astrocytes and neurons.
- Forming the NVU model in vitro. To get it we put the mix of neurons and endothelial cells on the bottom of culture plate wells. Then we set culture inserts (Corning-Costar USA) and put astrocytes at the top of them. We cultivated this mix of cells in the liquid containing DMEM with FBS, glutamine and antibiotics on 37°C with 5% CO2 [19]
2.2. Experiment design
- The «Control» group - the intact model of NVU.
- The «Minimum» group - samples with the lowest IL-6 level in the culture.
- The «Maximum» group - samples with the highest IL-6 level in culture.
- Hypoxia 1: N2-99 %, O2-1 %, CO2, t-37 С°.
- Hypoxia 2: N2-98 %, O2-2 %, CO2, t-37 С°.
- Hypoxia 3: N2-97 %, O2-3 %, CO2, t-37 С°.
- Hypoxia 4: N2-96 %, O2-4 %, CO2, t-37 С°.
2.3. Evaluation of NVU functionality
2.4. Statistical processing
3. Results
| TER | CG | HG 1 | HG 2 | HG 3 | HG 4 |
|---|---|---|---|---|---|
| 0 hours | 199,5 [197,25 − 201,50] |
197,0 [196,75 − 199,25] (p=0,15325) |
197,5 [196,25 − 199,25] (p=0,33156) |
192,5 [190,75 − 195,0] (p=0,04071) |
195,0 [194,75 − 196,50] (p=0,11689) |
| 1 hours | 204,25 [202,75 − 206,0] |
191,0 [189,75 − 193,0] (p=0,03) |
191,0 [189,50 − 192,5] (p=0,031) |
191,0 [189,75 − 193,25] (p=0,033) |
193,0 [191,50 − 195,0] (p=0,034) |
| 2 hours | 200,0 [196,75 − 203,50] |
185,0 [182,25 − 187,25] (p=0,054) |
191,5 [188,75 − 194,75] (p=0,04) |
192,0 [187,50 − 195,0] (p=0,066) |
193,0 [190,75 − 194,50] (p=0,04) |
| 4 hours | 194,5 [193 − 195,75] |
175,5 [174,5 − 176,75] (p=0,01046) |
177,0 [175,75 − 178,25] (p=0,01519) |
183,5 [182,0 − 185,5] (p=0,03291) |
189,0 [187,5 − 191,25] (p=0,14405) |
| 24 hours | 203,0 [200,75 − 205,5] |
141,0 [138,75 − 143,0] (p=0,01046) |
162,0 [160,0 − 164,0] (p=0,02092) |
179,5 [175,0 − 183,25] (p=0,01519) |
192,0 [191,0 − 192,75] (p=0,05314) |

| TER | CG | GMin | GMax |
|---|---|---|---|
| 0 hours | 198,0 [197,0 − 200,0] |
199,0 [197,0 − 199,0] (p=0,25) |
197,0 [195,0 − 198,0] (p=0,073) |
| 1 hours | 206,0 [205,0 − 207,0] |
197,0 [196,0 − 198,0] (p=0,00027) |
196,0 [196,0 − 197,0] (p=0,00016) |
| 2 hours | 203,0 [202,0 − 204,0] |
190,0 [188,0 − 192,0] (p= 0,00017) |
185,0 [185,0 − 188,0] (p= 0,00016) |
| 4 hours | 200,0 [196,0 − 203,0] |
168,0 [168,0 − 170,0] (p= 0,00016) |
151,0 [148,0 − 152,0] (p= 0,00017) |
| 24 hours | 199,0 [198,0 − 202,0] |
190,0 [188,0 − 192,0] (p= 0,00020) |
169,0 [169,0 − 172,0] (p= 0,00031) |
| TER | CG | HG 1 | HG 2 | HG 3 | HG 4 |
|---|---|---|---|---|---|
| 60 minutes | 99,5 [98,0 − 101,5] |
121,0 [117,5 − 124,25] (p=0,01008) |
119,5 [118,5 − 120,75] (p=0,0140 |
100,5 [99,5 − 101,25] (p=0,44084) |
101,0 [100,75 − 102,5] (p=0,37185) |
| 90 minutes | 99,5 [99,0 − 100,0] |
146,0 [143,75 − 148,0] (p=0,00971) |
139,0 [137,5 − 141,0] (p=0,01942) |
110,0 [107,75 − 112,0] (p=0,03228) |
107,0 [106,0 − 109,0] (p=0,05095) |
| TER | CG | GMin | GMax |
|---|---|---|---|
| 60 minutes | 99,5 [98,75 − 100,5] |
119,5 [118,75 − 121,0] (p=0,01046) |
114,5 [114,0 − 115,25] (p=0,01470) |
| 90 minutes | 99,5,0 [99,0 − 100,5] |
106,5 [105,75 − 107,25] (p=0,05314) |
109,5 [108,75 − 110,5] (p=0,03291) |
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| CHD | Congenital heart defects |
| CPB | cardiopulmonary bypass |
| NVU | neurovascular unit |
| SIR | Systemic Inflammatory Response |
| BBB | blood-brain barrier |
| TER | transendothelial resistance |
| LY | Lucifer Yellow |
| SIRS | Systemic Inflammatory Response Syndrome |
References
- Guenther U, Theuerkauf N, Frommann I, Brimmers K, Malik R, Stori, S., Scheidemann, M., Putensen, C., Popp, J. Predisposing and precipitating factors of delirium after cardiac surgery. A prospective observational cohort study. Annals of Surgery. 2013; 257: 1160–1167. [CrossRef]
- Hirata, Y. Cardiopulmonary bypass for pediatric cardiac surgery. General Thoracic and Cardiovascular Surgery. 2018; 66 (2): 65-70. [CrossRef]
- Engelman R, Baker RA, Likosky DS, Grigore A, Dickinson TA, Shore-Lesserson, L., Hammon JW. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2015 Aug;29(4):1104-13. [CrossRef]
- Spilka JM, O'Halloran CP, Marino BS, Brady KM. Perspective on Cerebral Autoregulation Monitoring in Neonatal Cardiac Surgery Requiring Cardiopulmonary Bypass. Front Neurol. 2021 Oct 5;12:74018. [CrossRef]
- Torb. ett BE, Baird, A., Eliceiri BP. Understanding the rules of the road: Proteomic approaches to interrogate the blood brain barrier. Frontiers in Neuroscience. 2015; 4; (9): 70. [CrossRef]
- Brough, D., Denes, A. Interleukin-1α and brain inflammation. IUBMB Life. 2015 May;67(5):323-30. [CrossRef]
- Kaushal, V., Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. Journal of Neuroscience. 2008; 28 (9): 2221-2230. [CrossRef]
- Naruka V, Salmasi MY, Arjomandi Rad A, Marczin N, Lazopoulos G, Moscarelli M, Casula, R., Athanasiou, T. Use of Cytokine Filters During Cardiopulmonary Bypass: Systematic Review and Meta-Analysis. Heart Lung Circ. 2022 Nov;31(11):1493-1503. [CrossRef]
- Christov A, Ottman JT, Grammas, P. Vascular inflammatory, oxidative and protease-based processes: Implications for neuronal cell death in Alzheimer's disease. Neurological Research. 2004; 26 (5): 540-546. [CrossRef]
- Minami, M., Satoh, M. Chemokines and their receptors in the brain: Pathophysiological roles in ischemic brain injury. Life Sciences. 2003; 5; 74(2-3): 321-7. [CrossRef]
- Hansen TG. Anesthesia-related neurotoxicity and the developing animal brain is not a significant problem in children. Paediatric anaesthesia. 2015; 25(1): 65-72. [CrossRef]
- Jevtovic-Todorovic, V. General Anesthetics and Neurotoxicity: How Much Do We Know?. Anesthesiology clinics. 2016; 34(3): 439-451. [CrossRef]
- Alvarez RV, Palmer C, Czaja AS, Peyton C, Silver G, Traube, Mourani PM, Kaufman, J. Delirium is a Common and Early Finding in Patients in the Pediatric Cardiac Intensive Care Unit. The Journal of pediatrics. 2018; 195: 206-212. [CrossRef]
- Gunn JK, Beca J, Hunt RW, Goldsworthy M, Brizard CP, Finucane K, Donath S, Shekerdemian LS. Perioperative risk factors for impaired neurodevelopment after cardiac surgery in early infancy. Arch Dis Child. 2016 Nov;101(11):1010-1016. [CrossRef]
- Jufar AH, Lankadeva YR, May CN, Cochrane AD, Marino B, Bellomo R, Evans RG. Renal and Cerebral Hypoxia and Inflammation During Cardiopulmonary Bypass. Compr Physiol. 2021 Dec 29;12(1):2799-2834. [CrossRef]
- Ferraris VA, Ballert EQ, Mahan, A. The relationship between intraoperative blood transfusion and postoperative systemic inflammatory response syndrome. The American Journal of Surgery. 2013; 205 (4): 457-465. [CrossRef]
- Migeot C, Ma I, El Arid JM, Soulé N, Garnier E, Neville, P., Lefort, B. Factors associated with red blood cells transfusion during first bloodless priming cardiac surgery in children. Arch Pediatr. 2022 Jul;29(5):370-375. [CrossRef]
- Ivkin, A.A., Grigoriev, E.V., Morgun, A.V. Substantiation of protection of a neurovascular unit in the clinical model of cardiopulmonary bypass. Complex Issues of Cardiovascular Diseases. 2022;11(4): 177-183. [CrossRef]
- Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, Wee JH, Choi SP. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis. 2013 Apr;75(4):342-7. [CrossRef]
- Khilazheva, E.D., Boytsova, E.B., Pozhilenkova, E.A., Solonchuk Yu.R., Salmina, A.B. Obtaining a three-cell model of a neurovascular unit in vitro. Cell Tiss. Biol. 2015; 9. (6): 447-451. [CrossRef]
- Ivkin AA, Grigoriev, E., Sinitskaya AV. Refraining from Packed Red Blood Cells in Cardiopulmonary Bypass Priming as a Method of Neuroprotection in Pediatric Cardiac Surgery. J Clin Med. 2023 Feb 12;12(4):1465. [CrossRef]
- Hao, X., Wei, W. Severe low cerebral oximetry in difficult cardiopulmonary bypass weaning of low body-weight infant: A case report and literature review. BMC Anesthesiol. 2020 Jun 27;20(1):159. [CrossRef]
- Wloch A, Boettcher W, Sinzobahamvya N, Cho MY, Redlin M, Dähnert, I., Photiadis, J. Bloodless priming of the cardiopulmonary bypass circuit: Determinants of successful transfusion-free operation in neonates and infants with a maximum body weight of 7 kg. Cardiol Young. 2018 Oct;28(10):1141-1147. [CrossRef]
- Liu T, Deng R, Wang X, Liu P, Xiao QX, Liu Q, Zhang, Y. Mechanisms of hypoxia in the hippocampal CA3 region in postoperative cognitive dysfunction after cardiopulmonary bypass. J Cardiothorac Surg. 2022 May 7;17(1):106. [CrossRef]
- Mutch WA, Ryner LN, Kozlowski P, Scarth G, Warrian RK, Lefevre GR, Wong TG, Thiessen DB, Girling LG, Doiron L, McCudden C, Saunders JK. Cerebral hypoxia during cardiopulmonary bypass: A magnetic resonance imaging study. Ann Thorac Surg. 1997 Sep;64(3):695-701. [CrossRef]



Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).